Hazards of Cytotoxic Drugs
|
|
|
- Clifton Hancock
- 10 years ago
- Views:
Transcription
1 38 H Y G E I A HYGEIA Vol.1, No.1 March-Aug, 09 Hazards of Cytotoxic Drugs 1 2 Kiron SS, Saritha M 1 Academy of Pharmaceutical Sciences, Medical College, Pariyaram, Kannur, Kerala. 2 Crescent College of Pharmaceutical Sciences, Madayipara, Payangadi, Kannur, Kerala. Abstract Cytotoxic drugs include any drug that inhibits or prevents the function of cells. Cytotoxic drugs are increasingly being used in a variety of healthcare settings, laboratories and veterinary clinics for the treatment of cancer and other medical conditions such as rheumatoid arthritis, multiple sclerosis and auto-immune disorders. ccupational exposure to hazardous drugs and the resulting potential health risk to healthcare workers first became a recognized safety concern in the 1970s. Published data related to the issue of occupational exposure prompted the ccupational Safety and Health Administration (SHA) to issue guidelines in 1986 for the handling of antineoplastic and other hazardous agents by healthcare personnel. Handling of cytotoxic drugs provides useful information for pharmacists, pharmacy technicians, medical and nursing staff, veterinary practitioners and others involved in handling these drugs, including people who clean up any spills. The guidance contains simple information on the potential health hazards and health surveillance, legal framework and the duties of employers and employees. It also gives useful tips on ways of controlling and monitoring exposure and appropriate waste disposal. Appropriate training, utilization of effective equipment and supplies, and strict compliance with detailed policies and procedures provide the best approach to reducing the potential health risks of occupational exposure to hazardous drugs. Key words: Cytotoxic drugs, Handling of antineoplastic agents, ccupational exposure The treatment of cancer involving the chemotherapy makes use of highly toxic drugs. These drugs act mainly by suppressing the multiplication of malignant cells. Alternatively they also inhibit all growing cells, and this includes the healthy cells as well. This might affect the cells of the healthy people who handle these drugs. In the early 1980 s, there was concern about the environmental contamination when handling cytotoxics. The mutagenic and allergic property of these drugs that were manifested in the personnel handling of drugs were of concern for the health care providers. The first procedural manual, that provided assistance in the formulation of guidelines for handling of cytotoxics in hospitals, was released by American Society of Hospital Pharmacist in Surveys in the United States have shown that there exists a lack of standardized procedural manuals or guidelines for handling of the cytotoxic drugs or.1 to deal with their spillage in hospitals What are cytotoxic drugs? Cytotoxic drugs are therapeutic agents intended for, but not limited to, the treatment of cancer. These drugs are known to be highly toxic to cells, mainly through their action on cell reproduction. Many have proved to be carcinogens, mutagens or teratogens. Cytotoxic drugs are increasingly being used in a variety of healthcare settings, laboratories and veterinary clinics for the treatment of cancer and other medical conditions such as rheumatoid arthritis, multiple.2 sclerosis and auto-immune disorders Potential health effect of cytotoxic drugs Current statistics show that one in three people have a lifelong risk of developing cancer. There is little scientific evidence currently available relating to whether working with cytotoxic drugs actually increases the risk of developing cancer or not. However, in the absence of such data, a strategy of prudent avoidance is recommended. In the workplace, occupational exposure may occur where control measures fail or are not in place. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles, ingestion and needle stick injuries resulting from the following activities: Drug preparation Drug administration Handling patient waste Transport and waste disposal or Spills. *For Correspondence: [email protected]
2 SS Kiron et al/ HYGEIA / Vol.1, No.1/March-Aug, Personnel likely to be involved in these activities include: Nurses and Medical officers Pharmacists Laboratory staff, and Cleaning, maintenance and waste disposal staff. Where control measures are not adequate, adverse health effects may result from occupational exposure. Health effects attributed to cytotoxic drugs exposure amongst people preparing and administering cytotoxic drugs include: Abnormal formation of cells and mutagenic activity Alterations to normal blood cell count Fetal loss in pregnant women and malformations in the offspring of pregnant women Abdominal pain, hair loss, nasal sores and vomiting Liver damage, and Contact dermatitis, local toxic or allergic reaction, which may result from direct contact with skin or mucous membranes. Safe handling of cytotoxics Cytotoxic medicines safety implies the safe management of the dispensing, reconstitution (if it is done in the pharmacy), transportation, administration of the cytotoxics and the final disposal of the used dosage form. It also implies the safety procedures be formulated in dealing with the management of the spillage. The personnel who are in daily contact with the cytotoxic drugs have a high chance being front of the cabinet produces an air curtain, exposed to these agents and becoming contaminated. The adverse effects of the cytotoxic drugs make it highly imperative to be careful in the handling of these cytotoxic drugs. Some of the measures in the safe handling of the cytotoxic drugs must include; Categorizing and separating these drugs to a specialized unit in the pharmacy, where adequate protective measures are taken like aprons, masks and glasses for the protection of the body and eyes Training and educating the pharmacists handling these agents about the risk involved and the protection to be taken while handling them. Educating the pharmacist involved on the measures to be taken in case of spillage of these drugs or while the transferring of these drugs into smaller packages for the use by the patients. Providing written procedural manual to deal with situations when spillage of cytotoxic occurs Special labeling of the containers should be instituted to ensure proper handling and disposal. Pregnant staff should never be allowed to handle 2 cytotoxics. Facilities to be provided where cytotoxic are handled and prepared The risk associated in the handling and administration of the cytotoxics drugs have resulted in the widespread use of safety cabinets for the preparation and dispensing of these products. The facility provided should be such that it serves the need of protection against the prepared cytotoxic drugs for the person handling it and the quality of the product is not affected which intern may affect the therapeutic efficacy for the patient. Vertical Laminar Flow Cabinet (VLFC), Isolators (Totally Enclosed Glove Boxes) may be used. Vertical laminar flow cabinet has the characteristic that the entire contaminated zone is under negative pressure. The operating principle is that air filtered through HEPA filter is passes over work surface. This air then passes through vents at the back and white front of the cabinet and is recirculated. Some of the air is exhausted and to compensate this more air is taken in through the front opening this creates a negative pressure in the cabinet. The balance between the cabinet down flow and the air drawn in at the which provides the basis for the product and personnel protection. Isolators are totally enclosed workstations with filtered air. Work can be done through glove ports or a half suit arrangement to access the working areas. Materials are introduced through a air lock or using an access port and docking device. At work the system is totally air sealed from the outside. The minimum requirements to protect staff when handling cytotoxic drugs at these different stages are outlined below Preparation of the dosage form in a controlled environment requires grown gloves of a suitable quality. Here there is no need of the protection for the eyes as the agents are handled in the negative pressure conditions of the controlled environment, which provides the protection for the personal. For preparation of the dosage form in the uncontrolled environment requires a gown, gloves, glasses for eye protection and a dust mask. For staff checking the prepared dosage form requires a long sleeved uniform and gloves. While transportation of the prepared dosage form to the ward no special requirement is needed, if they are transported in a suitable container, and the messenger is aware of the hazards While dealing with spills the protective measures required are a nonabsorbable overall with a plastic apron, a heavy-duty gloves, suitable eye protection and a respiratory mask. After the dosage has been administered the person handling the waste, should be dressed in long sleeved
3 SS Kiron et al/ HYGEIA / Vol.1, No.1/March-Aug, uniform, plastic apron, gloves of suitable quality, a suitable eye protection and a respiratory mask. Care should be taken that the waste are not discarded into drainage as this sewage may be recycled and reach the system, as the recycled sewage may be used for many general purpose like irrigating fields (as this recycled sewage may have a natural fertilizer quality). The toxic qualities of the discarded cytotoxics may reenter the cycle again, where the humans are at risk of being contamination. Here the risk is of higher magnitude as the volume of the people involved is greater. The methods of disposal of the commonly used drugs are discussed later and care should be taken to ensure the strict adherence to the procedure of disposal of the wastes to avoid contamination. The Risk Management Approach The aim of a risk management approach (outlined in Table 1) is to eliminate or reduce the risk of illness or injury associated with work. This generally involves a process of: Hazard identification Risk assessment Risk control, and Evaluation of control measures. Effective management of health and safety also involves: Consultation Personnel management Training Documentation of activities, and Regular review of the management system. Management of cytotoxic spills Restrict the movement of all the personnel to and from the area until decontamination is done. The person doing the decontamination should wear proper dressing with gloves, mask and eyeglasses of proper quality. The spilled material should be placed in a rigid container, if the spillage is a liquid, cover it with an absorbent cloth, leaving it there for sufficient time for the liquid to be absorbed. If the spilled material is powder, it should be covered with a wet cloth, and additional water added as required. All the absorbent material and spillage are transferred to a separate bag. All the surface contamination is washed with water and detergent by several rising with clean water. Absorbent clothes should not be used for this procedure. All potentially exposed skin surface should be washed with water and soap. Conclusions Exposure to the cytotoxins, though in small quantities over a long period of time is harmful to the human body. The exposure to these drugs increases the allergenic reaction in the personnel handling these drugs in the hospital. The above discussion attempts to discuss the hazards involved in the exposure of cytotoxic drugs. It also tries to outline the importance of maintaining a procedural manual in handling, dealing of spillage of cytotoxics and facilities needed in the disposal of cytotoxic drugs. Procedures for destruction or disposal of some commonly use cytotoxic drugs. The spillage that has been carefully collected using the proper protection and in the proper container are mainly destroyed by incineration at the very high temperature or by chemical degradation. The incinerating temperature and the chemical reagents used for denaturation of certain very commonly used cytotoxic drugs are outlined below. Table 1 Asparginase Bleomycin Carboplatin Cisplatin 800 C.. Destruction is incineration at. Chemically destroyed by denaturation with strong acid or alkali. Chemically destroyed by 5% Sodiumhydroxide, 10% Hypochlorite solution for 24 Hrs or alkaline potassium permanganate. Diluted with large volume of water and allowed to stand for 4/8 Hrs. n contact with skin should wash with water. Chemically destroyed by diluting with large volume of water or a 12% alkaline sodium borohydride. n contact with of water. A cream may be added if a stinging sensation is experienced.
4 SS Kiron et al/ HYGEIA / Vol.1, No.1/March-Aug, Cyclophosphamide Destruction is by incineration at 900 C Chemically destroyed by denaturation with 5% sodiumhydroxide or with 0.2M potassiumhydroxide in methanol for 24 hrs. n contact with skin wash well with water or soap. If eyes are contaminated, Cytarabine. 5% hydrochloric acid. n contact with of water. If eyes are contaminated, Dacarbazine 500 C 5% hydrochloric acid at ph 2 for 24 hrs or 10% sulphuric acid for 24hrs. n contact volume of water. If eyes are Doxorubicin Epirubicin 700 C. 10% sodium hypochlorite soaked for 24hrs. on contact with skin it may be washed with large volume of water or sodium bicarbonate solution. If eyes are 10% sodium hypochlorite soaked for 24hrs. n contact with skin it may be washed with large volume of water or sodium bicarbonate solution. If eyes are Etoposide alkaline potassium permanganate or 10% sodium hypochlorite soaked for 24 hrs. n contact with skin it may be washed with large volume of water. If eyes are contaminated, immediately 5 Fluro Uracil 700 C 5% sodium hydroxide or 10% sodium hypochlorite soaked for 24hrs. n contact with skin it may be washed with large volume of water or sodium bicarbonate solution. If eyes are
5 SS Kiron et al/ HYGEIA / Vol.1, No.1/March-Aug, Ifosphamide Dactinomycin Danorubicin Idarubicin Melphalan Methotrexate Mitomycin C 700 C 700 C 500 C 2N sodium hydroxide in dimethyl formamide soaked for 24 hrs. n contact 5% trisodium phosphate or 20% sodium hydroxide soaked for 24 hrs. n contact 10% sodium hypochlorite (1% available chorine) soaked for 24 hrs. n contact 10% sodium hypochlorite (1% available chorine) soaked for 24 hrs. n contact with of water or sodium bicarbonate solution. If eyes are contaminated, immediately 5% sodium thiosulphate in sodium hydroxide soaked for 24 hrs. n contact with skin it may be washed with large volume of water or sodium bicarbonate solution. If eyes are contaminated, immediately 1:1 mixture of 5% sodium hydroxide and sodium hypochlorite. n contact with of water and apply any cream if any stining is present. If eyes are contaminated, If sufficient quantity is inhaled or injected calcium folinate cover has to be provided. 2-5% sodium hydroxide or hydrochloric soaked for 12 hrs. n contact with skin it may be washed with large volume of water or sodium bicarbonate solution followed by soap and water. Avoid any hard creams. If eyes are contaminated, immediately
6 SS Kiron et al/ HYGEIA / Vol.1, No.1/March-Aug, Vincristine 5% sodium hydroxide or 10% sodium hypochlorite soaked for 24 hrs. n contact volume of water. If eyes are contaminated, Vinblastine Interferons 5% sodium hydroxide or 10% sodium hypochlorite soaked for 24 hrs. n contact 5% sodium hydroxide or 10% sodium hypochlorite soaked for 24hrs. n contact volume of water. If eyes are contaminated, immediately irrigate with normal saline soap and water. References 1. Allwood M, Wright P, Cytotoxic Handbook, 2nd ed., Victoria W, Handling of Cytotoxic Drugs in Work Place, January Cytotoxic Drug Safety Cabinets-Installation and use, Australian Standard AS2639, Wilson SJ. Safe disposal of some commonly used injectable antineoplastic drugs, J Clin Hosp. Pharm., 1983, 8: Update of information on disposal of cytotoxic drugs, January Turco S, Sterile Dosage forms, 4th ed., Premixed Cytotoxic Drugs, CSHH Data sheet covering Baxter Healthcare Ltd. 8. New Guidance on Safe Handling of Cytotoxic Drugs, HSE press release E , September Brown MS, Safe Handling of Chemotherapeutic Agents, University of Texas at Austin.
To provide direction for the safe handling, administration and disposal of hazardous drugs.
Subsection: MEDICATION Related terms: Cytotoxic Drugs, Antineoplastic Drugs Authorized by: Clinical Directors CS-04-02-01 Page 1 of 9 Date Established: October 2006 Date For Review: September 2014 Dates
Recommendations for the Safe Use of Handling of Cytotoxic Drugs
Recommendations for the Safe Use of Handling of Cytotoxic Drugs Introduction Cytotoxic drugs are toxic compounds and are known to have carcinogenic, mutagenic and/or teratogenic potential. With direct
This course was written for RN.ORG by an outside consultant and RN.ORG has rights for distribution but is not responsible for the contents.
Safe Handling of Hazardous Drugs WWW.RN.ORG Reviewed September, 2015, Expires September, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG,
Standard Operating Procedure for Dacarbazine in Animals
Standard Operating Procedure for Dacarbazine in Animals 1. Health hazards Dacarbazine, also known as DTIC, DIC, and Imidazole Carboxamide, is an antineoplastic chemotherapy drug used in the treatment of
Health and safety practices for health-care personnel and waste workers
12 Health and safety practices for health-care personnel and waste workers 12.1 Principles Health-care waste management policies or plans should include provision for the continuous monitoring of workers
Safe Handling of Cytotoxic Materials
Safe Handling of Cytotoxic Materials Kara Henman RN, MN, CON(C) Oncology Practice Consultant Cancer Care Nova Scotia What are hazardous drugs? Chemotherapy Immunosuppressive agents Biological agents Antiviral
Chemotherapy: Safety Protocols. Janet Modrakovic, BAS, CVT
Chemotherapy: Safety Protocols Janet Modrakovic, BAS, CVT The word chemotherapy strikes fear in the heart of every pet owner whose beloved pet has been diagnosed with cancer. The incidence of cancer in
HANDLING CYTOTOXIC DRUGS IN THE WORKPLACE
January 2003 HANDLING CYTOTOXIC DRUGS IN THE WORKPLACE MANAGING HEALTH & SAFETY RISKS ASSOCIATED WITH HANDLING CYTOTOXIC DRUGS IN THE HEALTHCARE INDUSTRY CONTENTS Corporate Statement...1 Section 1 Handling
Guidelines for the Management of Spillage of Cytotoxic Drugs. No changes have been made as evidence base remains current.
Guidelines for the Management of Spillage of Cytotoxic Drugs Date Approved by Network Governance May 2012 Date for Review May 2015 Changes Between Versions 3.0 and 4.0 No changes have been made as evidence
INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HANDLING OF H AZARDOUS DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED
Beware that ordinary prescription glasses do not provide adequate protection. This is also true with poorly fitting safety glasses.
Ethidium Bromide Introduction Ethidium bromide (EtBr) is widely used for visualization of nucleic acids in electrophoretic gels. EtBr forms fluorescent complexes, by intercalation of DNA, which are readily
GUIDELINES FOR THE SAFE HANDLING OF CYTOTOXIC DRUGS AND RELATED WASTE
Occupational Safety and Health Information Series GUIDELINES FOR THE SAFE HANDLING OF CYTOTOXIC DRUGS AND RELATED WASTE OCCUPATIONAL SAFETY & HEALTH SERVICE LABOUR DEPARTMENT OF TE TARI MAHI Prepared by
Safe Disposal Methods Management of Body Substances from Patients Undergoing and Following Cytotoxic Drug Therapy Background Hospital/ Institution Home Physician Nurse Nurse Aide Personnel handling waste
Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช
Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช Chemotherapy Agent. Low therapeutic index. -Increase risk for medication error. Hazardous
SAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010
SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information
British Columbia Cancer Agency
Page 1 of 8 RATIONALE To minimize the hazardous drug exposure of staff, patients and visitors to the BCCA Regional Centres, spills must be managed appropriately, according to established policies and procedures.
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS
GUIDANCE ON THE SAFE HANDLING OF MONOCLONAL ANTIBODY (mab) PRODUCTS 5 th Edition November 2015 NHS Pharmaceutical Quality Assurance Committee 2015 British Oncology Pharmacists Association Pharmaceutical
Cytotoxic Agents Safe Management For Nursing Students. Pat Stalker Clinical Educator, LRCP Feb 2015
Cytotoxic Agents Safe Management For Nursing Students Pat Stalker Clinical Educator, LRCP Feb 2015 Overview and Objectives Review key content of the nursing procedure Differentiate between Hazardous drugs
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
Guide for handling cytotoxic drugs and related waste
Guide for handling cytotoxic drugs and related waste Contents Chapter 1: Introduction... 3 Chapter 2: Legal requirements... 6 Chapter 3: Managing risks... 10 Chapter 4:Training... 16 Chapter 5: Personal
Chemotherapy Spill Response:
Chemotherapy Spill Response: Antineoplastic Spills Outside Of A Fume Hood Lisa Hudley, RN Training Coordinator Safety & Environmental Compliance William Guess Director Safety & Environmental Compliance
Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011
Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011 Safe Infectious Waste Handling and Transport Objective Waste Overview Roles and Responsibilities of Waste
Hazardous Precautions. Prepared By: Hazardous Precautions Working Group Updated: March 2014
Hazardous Precautions Prepared By: Hazardous Precautions Working Group Updated: March 2014 1 What are Hazardous Medications? They are therapeutic agents that are often used in the treatment of: cancer,
Minimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols
Environmental Health and Safety Minimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols Chemicals that are highly toxic or corrosive, known or suspected carcinogens, reproductive hazards,
File: Spill Response Plan for Hazard Chemicals and Mercury Spills. Orig. Date: 12/01/2005 Review Date: January Review Date: March 2010
File: Spill Response Plan for Hazard Chemicals and Mercury Spills Orig. Date: 12/01/2005 Review Date: January Review Date: March 2010 OSHA: 1910.120 EPA: 40CFR 112.7 Messiah College Spill Response Policy
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure TITLE: Safe Handling of Cytotoxic Drugs/Waste NUMBER: CC 05-055 Date Issued: August 2011 Page 1 of 11 Applies To: Holders of Interdisciplinary Clinical
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Response to Biological Spills in the Laboratory (Intentional or Accidental)
Response to Biological Spills in the Laboratory (Intentional or Accidental) Exposure Management For splash to eyes, mucous membranes, or broken area of the skin Irrigate eyes with clean water, saline or
Safe Handling of Oral Chemotherapy. Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL Rick.abbott@easternhealth.
Safe Handling of Oral Chemotherapy Rick Abbott Regional Pharmacy Manager, Systemic Therapy Eastern Health, NL [email protected] Conflict of Interest Declaration I have developed and delivered
Hazardous Drugs Spill Kit
Hazardous Drugs Spill Kit About the Joint Venture Baxter Pharmacy Services and CRG Healthcare have come together to produce the Hazardous Drugs Spill Kit Baxter Pharmacy Services Provides aseptically prepared
Cytotoxic and Biotherapies Credentialing Programme Module 6
Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will
Please contact your local Poison Control Centre: Australia 13 11 26 United States 1800 222 1222
MATERIAL SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF MATERIAL AND SUPPLIER SD169 SYN-1079 1H-indole-5-carboxamide CAS Registry No.: 1670-87-7 Supplier: SYNkinase Level 4, Building 21A, 528 Ruiqing Rd.
MATERIAL SAFETY DATA SHEET
Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. PRODUCT IDENTIFICATION 1.1 Product Name: Cyanogen Bromide Fibrinogen Fragments 1.2 Product REF: 459 1.3 Configuration: One (1) vial, 5.0 mg, lyophilized 1.4 Use of Product:
TITLE: Storage and Management of Hazardous Medications & Chemicals APPLIES TO: Pharmacy Staff
Administrative Policies and Procedures for MOH hospitals /PHC Centers NO. OF PAGES: ORIGINAL DATE: REVISION DATE : 1.0 PURPOSE 1.1 To develop a set of safety rules and regulations that address the identification,
4729-16-11 Hazardous Drugs Compounded by a Prescriber.
ACTION: Original DATE: 11/30/2015 8:57 AM 4729-16-11 Hazardous Drugs Compounded by a Prescriber. (A) A facility where a prescriber is compounding or handling hazardous drugs shall be licensed as a terminal
CHEMICAL SPILL MANAGEMENT GUIDELINES
WHS Unit CHEMICAL SPILL MANAGEMENT GUIDELINES Contents 1 Purpose... 2 2 Scope... 2 3 Definitions... 2 4 Roles and Responsibilities... 2 5 General... 2 6 Defining Major or Minor Spill... 3 7 Major Spill
COMPOSITION / INFORMATION ON INGREDIENTS
MATERIAL SAFETY DATA SHEET DAMTITE WATERPROOFER- WHITE 01071, 01211, 01451 DAMTITE POWDER FOUNDATION WATERPROOFER GRAY 02451 SECTION I. COMPANY & PRODUCT INFORMATION Product Identification Manufacturer
Guidance sheet 4: Chemical Spill Management
Guidance sheet 4: Chemical Spill Management The purpose of this Guidance sheet is to provide information on how to prevent chemical spills and /or manage and respond to spills in the event that they do
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET SIMULATED INSULIN, REGULAR INSTRUCTIONAL USE ONLY. NOT FOR HUMAN OR ANIMAL USE 1. PRODUCT AND COMPANY IDENTIFICATION Product Name: Demo Dose Simulated Insulin, Regular Product
Creation Date: 20.07.1999 Revision Date: 11.08.2009 Page: 1 of 7
Creation Date: 20.07.1999 Revision Date: 11.08.2009 Page: 1 of 7 1. Identification of Products Product Name: Guardex Chlor-Out Product Code: 20 35 568 010 Chemical Name: Sodium Sulphite Distributed by:
Mechanical Systems Competency 1.20
Competency 1.20 Mechanical systems personnel shall demonstrate a working level knowledge of the safety and health fundamentals of mechanical systems and/or components. 1. Supporting Knowledge and Skills
Infection Control Manual - Section 8 Sharps & Clinical Waste. Infection Prevention Control Team
Title Document Type Document Number Version Number Approved by Infection Control Manual - Section 8 Sharps & Clinical Waste Policy IPCT001/10 3 rd Edition Infection Control Committee Issue date August
Position Statement: Safe handling of monoclonal antibodies in healthcare settings
Position Statement: Safe handling of monoclonal antibodies in healthcare settings Introduction Monoclonal antibodies (MABs) were introduced into clinical practice in the mid 1980s, with their use in the
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
ZeoMed. spill management systems. www.enware.com.au. Infectious & Cytotoxic Spills. Travel Sickness Clean up. Large Spills Control PROTECTION FROM
Infectious & Cytotoxic Spills Travel Sickness Clean up Large Spills Control ZeoMed spill management systems PROTECTION FROM Blood borne pathogens Infectious diseases Biohazards Cytotoxic hazards Chemicals
Section 4. Toxicology
Section 4 Toxicology Occupational Health Any chemical you use incorrectly can result in over-exposure leading to adverse health effects immediately or in the future. All hazardous materials can be handled
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ HAZARD? HAZARD ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ ENCLOSURE Substitution ส งค กคามซ งอาจเป นอ นตรายต
Particularly Hazardous Substances (PHS) Standard Operating Procedure (SOP)
Particularly Hazardous Substances (PHS) Standard Operating Procedure (SOP) Formaldehyde, formalin, paraformaldehyde solutions, and paraformaldehyde solids Principal Investigator: Room & Building #: Department:
Technical Data Sheet
Februar, 2014 Technical Data Sheet PLA Polylactide Cas No. 9051-89-2 PLA is a thermoplastic resin derived from annually renewable resources Product Characteristics Typical Properties Value Unit Physical
MATERIAL SAFETY DATA SHEET
Page 1 of 4 PRODUCT NAME : COMPANY DETAILS Company Name LABSCAN ASIA CO., LTD. Address 24 Rama 1 Road, Pathumwan, Bangkok 10330 Thailand Tel. / Fax Tel : 662-613-7911-4 Fax : 662-613-7915 Emergency Tel.
CHEMICAL SPILL RESPONSE GUIDE
HEMIAL SPILL RESPONSE GUIDE Revised 2000 TABLE OF ONTENTS Emergency Phone Numbers Introduction - hemical Spill Response Spill Response Procedures - Major Spill Spill Response Procedures - Minor Spill Spills
Biosafety Spill Response Guide
Yale University Office of Environmental Health & Safety Biosafety Spill Response Guide Office of Environmental Health & Safety 135 College Street, 1 st Floor, New Haven, CT 06510 Telephone: 203-785-3550
Tools for Policy Development: Recommendations for handling linens exposed to hazardous drugs
Tools for Policy Development: Recommendations for handling linens exposed to hazardous drugs What is your laundry s policy for handling linens that may have been exposed to hazardous drugs? This question
GUIDELINES TO PREVENT TRANSMISSION INFECTIOUS DISEASES IN SCHOOLS
GUIDELINES TO PREVENT TRANSMISSION OF INFECTIOUS DISEASES IN SCHOOLS May 1991 Precautions, Procedures and Instructions for Handling Body Fluids DUVAL COUNTY PUBLIC SCHOOLS CONTENTS PAGE Introduction...
LiAiSON. Formaldehyde. In This Issue. How does Formaldehyde affect human health?
LiAiSON OCTOBER Marwell Medical Newsletter Formaldehyde How does Formaldehyde affect human health? Formaldehyde is toxic by inhalation, by skin contact, and by swallowing. Breathing Formaldehyde vapours
Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic Chemotherapy for Adults in the Community Setting
Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic Chemotherapy for Adults in the Community Setting Guideline for the Safe Handling and Administration of Subcutaneous Cyotoxic
SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT
Revision Date November 2012 Revision 9 1 / 5 SAFETY DATA SHEET According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier
Clinical Waste Management & Sharps Injury Prevention. Clinical Skills
Clinical Skills Clinical Waste Management and Sharps Injury Prevention Clinical Skills and Simulation Team Cardiff and Vale Waste Management Team Aims & Outcomes Aims & Outcomes The aim of this module
ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs
Drug Distribution and Control: Preparation and Handling Technical Assistance Bulletins 49 ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs In 1985, the ASHP Technical Assistance
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET SECTION 1 - CHEMICAL PRODUCT & COMPANY IDENTIFICATION Pfizer Consumer Healthcare Pfizer Inc 201 Tabor Road Morris Plains, New Jersey 07950 Emergency telephone Hours of operation
TRICHLOROACETIC ACID SOLUTION Department of Pharmacy Duke University Medical Center Box 3089 Durham, NC 27710 919-684-5125
Page 1 of 5 1. IDENTIFICATION OF SUBSTANCE Name: Manufacturer: TRICHLOROACETIC ACID SOLUTION Department of Pharmacy Duke University Medical Center Box 3089 Durham, NC 27710 919-684-5125 Information Department:
Spillage Waste Management
Spillage Waste Management Patient Information Introduction This leaflet contains the answers to some questions patients and carers may have about the disposal of chemotherapy waste and the management of
Chemical Spill Response Guideline
ChemicalSpillResponseGuideline Despite the best efforts of researchers to practice safe science in the laboratory, accidents resulting in the release of chemicals will occur. For this reason, it is essential
Waste Type Classification Colour Coding Disposal Method
Sharps Disposal Introduction PHS Waste Management provides a responsive, reliable and flexible sharps disposal services to help eliminate injuries from sharps, needles and syringes. Conscious of our Duty
Appendix J IBC Biohazard Spill Management Plan
OVERVIEW Prevention is the most important part of any spill management plan. Be sure to read and understand standard operating procedures (SOP s) and protocols for safe manipulation of biohazards before
Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014
Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014 I, Kareena Arthy, Chief Executive Officer of the Australian Pesticides and Veterinary
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET Revision date: 02/20/2012 Revision number: 0 1. PRODUCT AND COMPANY IDENTIFICATION Product Name ProClean Drain Cleaner Contact Manufacturer Duracable Manufacturing Company 300
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES
Perth and Smiths Falls District Hospital Attention: Manager, Quality 60 Cornelia Street, West Smiths Falls, Ontario K7A 2H9 CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES This guide has been prepared
SAFETY DATA SHEET BOSTIK AQUAGRIP 536
Revision Date November 2014 1 / 6 SAFETY DATA SHEET BOSTIK AQUAGRIP 536 According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1.
PRODUCT SAFETY DATA SHEET
Page 1/5 Date of Submitted: January 21, 2014 This product is a consumer product which is used in a hermetically sealed state. So, it is not an object of the SDS system. This document is provided to customers
Leader s Guide E4017. Bloodborne Pathogens: Always Protect Yourself
E4017 Bloodborne Pathogens: Always Protect Yourself 1 Table of Contents Introduction 3 Video Overview.3 Video Outline.4 Preparing for and Conducting a Presentation. 7 Discussion Ideas..8 Quiz..9 Quiz Answers...11
Material Safety Data Sheet ISO/DIS 11014 / 29 CFR 1910.1200 / ANSI Z400.1
Page 1/5 1 Identification of substance Product details Product number: 2315 Manufacturer/Supplier: Merial Limited 115 Transtech Drive Athens, GA 30601 Tel.: +1 706 548 9292 Information department: MSDS
Safety Data Sheet Avesta Neutralization Agent 502
Safety Data Sheet Avesta Neutralization Agent 502 This Safety Data Sheet contains information to help users understand the potential hazards relating to this product and provides advice for risk management.
OFFICIAL PUBLICATIONS. Hazardous Pharmaceuticals (Including Cytotoxic Drugs): Guidelines for Handling and Disposal (1997)
OFFICIAL PUBLICATIONS Hazardous Pharmaceuticals (Including Cytotoxic Drugs): Guidelines for Handling and Disposal (1997) Guidelines for Handling and Disposal Published by the Canadian Society of Hospital
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone
Safe Operating Procedure
Safe Operating Procedure (Revised 12/11) SPILL AND EXPOSURE RESPONSE FOR BIOHAZARDOUS MATERIALS (INCLUDING RECOMBINANT NUCLEIC ACIDS) (For assistance, please contact EHS at (402) 472-4925, or visit our
1. Product and Company Identification
Material Safety Data Sheet Oligonucleotide (unmodified and modified) English 1 / 7 1. Product and Company Identification 1.1 Product identifier Chemical Name / Trade Name: Synthetic Nucleic Acid (Oligonucleotide)
Calendula Extract Safety Data Sheet
Calendula Extract Safety Data Sheet SECTION 1: Identification of the substance/mixture and of the company/undertaking Product name: Calendula Extract Product code: 305-109 Supplier: Majestic Mountain Sage
Emergency Telephone (800) 551-7176
MATERIAL SAFETY DATA SHEET SECTION 1 - PRODUCT & COMPANY IDENTIFICATION 1501 East Woodfield Road Suite 300 East Schaumburg, IL 60173 (847) 969-2700 Product Identifier: Chemical Name: Category: Mesna Detoxifying
PRODUCT ID: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION
SECTION 15: REGULATORY INFORMATION This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all the information required by the
Safety Data Sheet SOMAmer Reagent
SECTION 1: Identification Safety Data Sheet SOMAmer Reagent 1.1 Product identifier Product name SOMAmer Reagent (aptamer) 1.2 Supplier s details Name Address Email SomaLogic, Inc. 2945 Wilderness Place
Sodium Sulphite Anhydrous
Revision date 08-04-2016 1.1 Product identifier Sodium Sulphite Anhydrous Section 1: Identification of the substance/ mixture and of the company/ undertaking. Product name Other names Sodium Sulphite Anhydrous
: MR MUSCLE Window & Glass Cleaner
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product information Product identifier : Relevant identified uses of the substance or mixture and uses advised against : Hard Surface
Dacarbazine for Injection, USP Dacarbazine Antineoplastic
MATERIAL SAFETY DATA SHEET SECTION 1 - PRODUCT & COMPANY IDENTIFICATION 1501 East Woodfield Road Suite 300 East Schaumburg, IL 60173 (847) 969-2700 Product Identifier: Chemical Name: Category: Emergency
Pharmaceutical Waste Program for Inpatient Pharmacy. Portland Service Area Pharmacy Leadership Team
Pharmaceutical Waste Program for Inpatient Pharmacy Portland Service Area Pharmacy Leadership Team What is Pharmaceutical Waste? Pharmaceutical waste is waste generated through IV preparation, compounding,
MATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. PRODUCT AND COMPANY IDENTIFICATION Name: XYLOCAINE SOLUTIONS WITH EPINEPHRINE Address/Phone No.: DENTSPLY Pharmaceutical 3427 Concord Road York, PA 17402 Phone: 717-757-0200
Protocol for Disinfection of Cell Culture and Tissue Culture in Media:
Protocol for Disinfection of Cell Culture and Tissue Culture in Media: Location: Hickory Hall 001 Director: Dr. Guido Verbeck DECONTAMINATION OF CELL CULTURE WASTE Cell culture has become a common laboratory
Vanderbilt University Medical Center Pharmaceutical Waste Program USER INSERVICE
Vanderbilt University Medical Center Pharmaceutical Waste Program USER INSERVICE Training and Education Plan This session is intended to train and provide super-users with necessary resources to effectively
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING SULPHURIC ACID DRAIN CLEANER
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product name Product No. SULPHURIC ACID DRAIN CLEANER H094 1.2. Relevant identified uses of the
MATERIAL SAFETY DATA SHEET
Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Greenstone LLC 100 Route 206 North Peapack, NJ 07977 800-435-7095 Emergency telephone number: CHEMTREC (24 hours):
: Water and Glycol Leak Detection Solution
Water and Glycol Leak Detection Solution Safety Data Sheet according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations Date of issue: 05/05/2015 Version: 1 SECTION
MATERIAL SAFETY DATA SHEET Description: SAF DRAIN Revision Number: 00
GRANULAR, ALKALINE DRAIN CLEANER GENERAL SAF-DRAIN is a powerful alkaline drain cleaner designed so that the product reaches the problem area before the reaction takes place. It effectively cleans organic
BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN
BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN Facility Name: University of Arkansas at Little Rock Date of Preparation: 01-17-06 In accordance with the OSHA Bloodborne Pathogens Standard, 1910.1030, the following
